| Print
Fate Therapeutics (FATE)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Address
3535 General Atomics Court
Suite 200
San Diego
CA
USA
92121
Telephone
+1 858 875-1800
Forecast key dates
| Name | Key Date |
|---|---|
| Fate Therapeutics Inc Fourth Quarter Earnings Results for 2026 | 2027-02-26T00:00:00 |
| Fate Therapeutics Inc Annual Report for 2026 | 2027-02-26T00:00:00 |
| Fate Therapeutics Inc Third Quarter Earnings Results for 2026 | 2026-11-13T00:00:00 |
| Fate Therapeutics Inc Second Quarter Earnings Results for 2026 | 2026-08-12T00:00:00 |
| Fate Therapeutics Inc Annual General Meeting for 2026 | 2026-05-29T09:00:00 |
| Fate Therapeutics Inc First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
| Leerink Partners 2026 Global Healthcare Conference | 2026-03-09T09:20:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Leerink Partners 2026 Global Healthcare Conference | 2026-03-09T09:20:00 |
| Fate Therapeutics Inc Fourth Quarter Earnings Results for 2025 | 2026-02-26T00:00:00 |
| Fate Therapeutics Inc Annual Report for 2025 | 2026-02-26T00:00:00 |
| Fate Therapeutics Inc Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
| Cantor Global Healthcare Conference 2025 | 2025-09-04T10:55:00 |
| 2025 Wells Fargo Healthcare Conference | 2025-09-03T00:00:00 |
| Fate Therapeutics Inc Second Quarter Earnings Results for 2025 | 2025-08-12T00:00:00 |
| Fate Therapeutics Inc Annual General Meeting for 2025 | 2025-05-29T09:00:00 |
| Fate Therapeutics Inc First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
| Leerink Partners Global Healthcare Conference | 2025-03-12T11:20:00 |
| Barclays 27th Annual Global Healthcare Conference | 2025-03-11T08:30:00 |
| Fate Therapeutics Inc Fourth Quarter Earnings Results for 2024 | 2025-03-05T00:00:00 |
| Fate Therapeutics Inc Annual Report for 2024 | 2025-03-05T00:00:00 |
| TD Cowen 45th Annual Health Care Conference | 2025-03-03T11:50:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.